510(k) K050665
K050665 is an FDA 510(k) premarket notification submitted by Dade Behring, Inc. for the device "N ANTISERA TO HUMAN COMPLEMENT FACTORS (C3C, C4)". The FDA issued a decision of Substantially Equivalent on May 2, 2005. The device falls under product code CZW (Complement C3, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. Dade Behring, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 2, 2005
- Date Received
- March 15, 2005
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C3, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5240
- Review Panel
- IM
- Submission Type